Olmesartan medoxomil [Olmetec; Sankyo] and mitiglinide [Glufast; Kissei] have been approved in Japan

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1425, 2004-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitiglinide [Glufast] 5mg and 10mg tablets in combination with an α-glucosidase inhibitor have been approved in Japan for glycaemic control

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil

By Warner G.T.   Jarvis B.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1345-1353

Adis International

Access to resources Recommend Favorite

Pitavastatin [`Livalo'; Sankyo] has been launched in Japan, its first market worldwide

By  

Inpharma, Vol. 1, Iss. 1407, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Olmesartan medoxomil beneficial in hypertension

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil/Amlodipine

By Sanford Mark   Keam Susan J.  

Drugs, Vol. 69, Iss. 6, 2009-01 ,pp. : 717-729

Adis International

Access to resources Recommend Favorite